Fanconi's Anemia: Tumor-like Warts, Hyperpigmentation Associated With Deranged Keratinocytes, and Depressed Cell-Mediated Immunity

Archives of Dermatology

Volumn 118, Issue 4, 1982, Pages 249-252

  Johansson, Eija ^a   Niemi, Kirsti Maria ^a   Siimes, Martti ^a   Pyrhönen, Seppo ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD AND HEMOPOIETIC SYSTEM; CASE REPORT; CELLULAR IMMUNITY; CHROMOSOME ABERRATION; FANCONI ANEMIA; GROWTH RETARDATION; HEREDITY; HYPERPIGMENTATION; HYPOGONADISM; KERATINOCYTE; PANCYTOPENIA; SUN EXPOSURE; VERRUCA VULGARIS;

ADULT; ANEMIA, APLASTIC; CASE REPORT; CELL NUCLEUS; FANCONI ANEMIA; HUMAN; HYPERSENSITIVITY, DELAYED; LEUKOCYTE COUNT; MALE; PIGMENTATION DISORDERS; SKIN; SKIN DISEASES; T-LYMPHOCYTES; WARTS;

EID: 85047691751     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.118.4.249     Document Type: Article

References (33)

1. Fanconi G: Familiäre infantile perniziosaartige Anämie (perniziöses Blutbild und Konstitution). Jb Kinderheilkd 1927;117:257–280.
2. Fanconi G: Familial constitutional panmyelocytopathy, Fanconi's anemia (F.A.): I. Clinical aspects. Semin Hematol 1967;4:233–240.
3. Texier L, Maleville J: La symptomatologie cutanée de l'anémie perniciosiforme de Fanconi: Rapports avec la dyskératose congenitale de Zinsser-Cole-Engman. Ann Dermatol Venereol 1963;90:553–568.
4. Swift MR, Hirschhorn K: Fanconi's anemia: Inherited susceptibility to chromosome breakage in various tissues. Ann Intern Med 1966;65:496–503.
5. Schmid W: Familial constitutional panmyelocytopathy, Fanconi's anemia (F.A.): II. A discussion of the cytogenetic findings in Fanconi's anemia. Semin Hematol 1967;4:241–249.
6. Dosik H, Hsu LY, Todaro GJ, et al: Leukemia in Fanconi's anemia: Cytogenetic and tumor-virus susceptibility studies. Blood 1970;36:341–351.
7. Schroeder TM, Kurth R: Spontaneous chromosomal breakage and high incidence of leukemia in inherited disease. Blood 1971;37:96–112.
8. Catalona WJ, Taylor PT, Rabson AS, et al: A method for dinitrochlorobenzene contact sensitization: A clinicopathological study. N Engl J Med 1972;286:399–402.
9. Felsburg PJ, Edelman R, Gilman RH: The active E rosette test: Correlation with delayed cutaneous hypersensitivity. J Immunol 1976; 116:1110–1114.
10. Pyrhönen S, Penttinen K: Wart-virus antibodies and the prognosis of wart disease. Lancet 1972;2:1330–1332.
11. Powell L, Pollard M, Jenkins JL: Treatment of condyloma acuminatum by autogenous vaccine. South Med J 1970;63:202–205.
12. Spencer ES, Andersen HK: Clinically evident, non-terminal infections with herpesviruses and the wart virus in immunosuppressed renal allograft recipients. Br Med J 1970;3:251–254.
13. Perry TL, Harman L: Warts in diseases with immune defects. Cutis 1974;13:359–362.
14. Koranda FC, Dehmel EM, Kahn G, et al: Cutaneous complications in immunosuppressed renal homograft recipients. JAMA 1974;229:419–424.
15. Morison WL: Viral warts, herpes simplex, and herpes zoster in patients with secondary immune deficiencies and neoplasms. Br J Dermatol 1975;92:625–630.
16. Brodersen I, Genner J, Brodthagen H: Tuberculin sensitivity in BCG vaccinated children with common warts. Acta Derm Venereol 1974;54:291–292.
17. Morison WL: Cell-mediated immune responses in patients with warts. Br J Dermatol 1975;93:553–556.
18. Reid TMS, Fraser NG, Kernohan IR: Generalized warts and immune deficiency. Br J Dermatol 1976;95:559–564.
19. Johansson E, Pyrhönen S, Rostila T: Wart and wart-virus antibodies in patients with systemic lupus erythematosus. Br Med J 1977;1:74–76.
20. Jablonska S, Orth G, Jarzabek-Chorzelska M, et al: Neues auf dem Gebiet der Warzenviren. Hautarzt 1979;30:411–417.
21. Bundino S, Zina AM, Bernengo MG: Dyskeratosis congenita with epidermodysplasia verruciformis of Lewandowsky and Lutz. Dermatologica 1978;156:15–23.
22. Addison M, Rice MS: The association of dyskeratosis congenita and Fanconi's anemia. Med J Aust 1965;1:797–799.
23. Gutman A, Frumkin A, Adam A, et al: X-linked dyskeratosis congenita with pancytopenia. Arch Dermatol 1978;114:1667–1671.
24. Scoggins RB, Prescott KJ, Asher GH, et al: Dyskeratosis congenita with Fanconi-type anemia: Investigations of immunologic and other defects. Clin Res 1971;19:409–412.
25. Abels D, Reed WB: Fanconi-like syndrome: Immunologic deficiency, pancytopenia, and cutaneous malignancies. Arch Dermatol 1973;107:419–423.
26. Glinski W, Jablonska S, Langner A, et al: Cell-mediated immunity in epidermodysplasia verruciformis. Dermatologica 1976;153:218–227.
27. Pedersen FK, Hertz H, Lundsteen C, et al: Indication of primary immune deficiency in Fanconi's anemia. Acta Paediatr Scand 1977;66:745–751.
28. Swift M, Zimmerman D, McDonough ER: Squamous cell carcinomas in Fanconi's anemia. JAMA 1971;216:325–326.
29. Todaro GJ, Green H, Swift MR: Susceptibility of human diploid fibroblast strains to transformation by SV 40 virus. Science 1966;153:1252–1254.
30. Jablonska S, Dabrowski J, Jakubowicz K: Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res 1972;32:583–589.
31. Yabe Y, Yasui M: Epidermodysplasia verruciformis: Viral particles in early malignant lesions. J Invest Dermatol 1978;71:225–228.
32. Bloom GE, Warner S, Gerald PS, et al: Chromosome abnormalities in constitutional aplastic anemia. N Engl J Med 1966;274:8–14.
33. Peterson RDA, Kelly WD, Good RA: Ataxia-telangiectasia: Its association with a defective thymus, immunological deficiency disease, and malignancy. Lancet 1964;1:1189–1193.